MK-0366

Known as: MK 366, MK 0366, MK366 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2017
051019762017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A new, compact UCLH Mk 2.5 EIT system has been developed and calibrated for EIT imaging of the head. Improvements include… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
PURPOSE To compare the accuracy and consistency of corneal flap thickness in the right and left eye created by three different… (More)
Is this relevant?
2002
2002
PURPOSE To evaluate flap dimension, flap thickness, hinge size, and cut deterioration with second blade use with the Nidek MK… (More)
Is this relevant?
1983
1983
Norfloxacin (MK-0366) is a new antibacterial agent, closely related to nalidixic acid, with broad spectrum activity against Gram… (More)
Is this relevant?
1983
1983
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… (More)
Is this relevant?
1982
1982
MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia… (More)
  • figure 1
Is this relevant?
1982
1982
The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid… (More)
  • table 1
Is this relevant?
1982
1982
A high-performance liquid chromatographic method for the analysis of norfloxacin (MK-366) [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7… (More)
Is this relevant?
1982
1982
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… (More)
  • table 1
Is this relevant?
1981
1981
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin… (More)
Is this relevant?